Renaissance Technologies
LEXX icon

Renaissance Technologies’s Lexaria Bioscience LEXX Stock Holding History

Renaissance Technologies’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.7K Buy
16,300
+700
+4% +$508 ﹤0.01% 3192
2025
Q4 		$9.63K Buy
15,600
+5,500
+54% +$5.21K ﹤0.01% 3170
2025
Q3 		$9.62K Buy
+10,100
New +$9.77K ﹤0.01% 3449
2024
Q3 		– Sell
-22,800
Closed -$63.4K – 3735
2024
Q2 		$63.4K Buy
+22,800
New +$68.4K ﹤0.01% 3258
2023
Q4 		– Sell
-12,900
Closed -$13K – 3947
2023
Q3 		$13K Buy
12,900
+2,200
+21% +$2.01K ﹤0.01% 3564
2023
Q2 		$8K Sell
10,700
-2,900
-21% -$3.76K ﹤0.01% 3834
2023
Q1 		$37K Buy
13,600
+2,100
+18% +$5.98K ﹤0.01% 3722
2022
Q4 		$28K Sell
11,500
-400
-3% -$957 ﹤0.01% 3902
2022
Q3 		$29K Buy
11,900
+400
+3% +$1.14K ﹤0.01% 3849
2022
Q2 		$34K Buy
+11,500
New +$30.8K ﹤0.01% 4058
2021
Q3 		– Sell
-17,200
Closed -$120K – 3673
2021
Q2 		$120K Buy
+17,200
New +$102K ﹤0.01% 3338

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Renaissance Technologies's LEXX Position: Q1 2026 in Review

Renaissance Technologies increased its Lexaria Bioscience (LEXX) stake by 4.5% in Q1 2026, buying an estimated $508 and bringing the position to 16,300 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3192.

Renaissance Technologies first reported a position in LEXX in Q2 2021 and has held it in 11 quarters since. The position peaked at $120K in Q2 2021. 28 funds tracked by Wall St. Rank hold LEXX as of Q1 2026.

  • Renaissance Technologies held 16,300 shares of Lexaria Bioscience worth $12.7K as of Q1 2026.
  • Renaissance Technologies bought 700 Lexaria Bioscience shares in Q1 2026, an estimated $508.
  • Lexaria Bioscience made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #3192 holding.
  • Renaissance Technologies first reported a position in Lexaria Bioscience in Q2 2021 and has held it in 11 quarters since.
  • Renaissance Technologies's Lexaria Bioscience position peaked at $120K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.